Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
- PMID: 34733353
- PMCID: PMC8548872
- DOI: 10.15420/icr.2021.20
Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
Abstract
Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion.
Keywords: Transradial approach; biopsy; myocarditis.
Copyright © 2021, Radcliffe Cardiology.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to declare. Availability of data: Data are available on request from the corresponding author. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Figures
References
-
- Frustaci A, Pieroni M, Chimenti C. atl>The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Hear J. 2002;3:348–53. - PubMed
Publication types
LinkOut - more resources
Full Text Sources